Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEPtalk 2 pilot trial of VZIG versus aciclovir for post-exposure prophylaxis against chickenpox in children with cancer
ISRCTN48257441Phase 3Completed
- Sponsor
- University of Birmingham
- Start
- Jan 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 3, randomised, open-label trial in chickenpox comparing VZIG with Aciclovir (2 arms). Started Jan 2014; status: completed.
02
Drugs
human varicella-zoster immune globulinaciclovir
03
Conditions
chickenpox
Beyond the preview
Go deeper on ISRCTN48257441.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN48257441.